RNA drugs and nonviral nanocarriers in oncology – present status and emerging concepts

This publication has 158 references indexed in Scilit:

• SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer
  Biomedical Microdevices, 2024
• Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
  Advanced Science, 2021
• Synthetic in vitro transcribed lncRNAs (SINEUPs) with chemical modifications enhance target mRNA translation
  FEBS Letters, 2020
• The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
  The Prostate, 2019
• MicroRNA replacement therapy in cancer
  Journal of Cellular Physiology, 2019
• Current knowledge on exosome biogenesis and release
  Cellular and Molecular Life Sciences, 2017
• Hepatocyte‐Specific Delivery of siRNAs Conjugated to Novel Non‐nucleosidic Trivalent N‐Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
  ChemBioChem, 2015
• Bioinformatics of siRNA Design
  2013
• MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs
  Journal of Molecular Medicine, 2011
• Size matters: Molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle
  Journal of Biomedical Materials Research, 1999